Global IBS Treatment Market Size, Status and Forecast 2020-2026

    • ID: AR2947223
    • 30 July, 2020
    • Other
    • Region: Global
    • 132 Pages
    • QYResearch

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered: Ranking by IBS Treatment Revenue
    • 1.4 Market by Type
      • 1.4.1 Global IBS Treatment Market Size Growth Rate by Type: 2020 VS 2026
      • 1.4.2 IBS-D
      • 1.4.3 IBS-C
      • 1.4.4 IBS-M
    • 1.5 Market by Application
      • 1.5.1 Global IBS Treatment Market Share by Application: 2020 VS 2026
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
      • 1.5.4 Research Laboratories
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Global IBS Treatment Market Perspective (2015-2026)
    • 2.2 Global IBS Treatment Growth Trends by Regions
      • 2.2.1 IBS Treatment Market Size by Regions: 2015 VS 2020 VS 2026
      • 2.2.2 IBS Treatment Historic Market Share by Regions (2015-2020)
      • 2.2.3 IBS Treatment Forecasted Market Size by Regions (2021-2026)
    • 2.3 Industry Trends and Growth Strategy
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis
      • 2.3.5 IBS Treatment Market Growth Strategy
      • 2.3.6 Primary Interviews with Key IBS Treatment Players (Opinion Leaders)

    3 Competition Landscape by Key Players

    • 3.1 Global Top IBS Treatment Players by Market Size
      • 3.1.1 Global Top IBS Treatment Players by Revenue (2015-2020)
      • 3.1.2 Global IBS Treatment Revenue Market Share by Players (2015-2020)
      • 3.1.3 Global IBS Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 3.2 Global IBS Treatment Market Concentration Ratio
      • 3.2.1 Global IBS Treatment Market Concentration Ratio (CR5 and HHI)
      • 3.2.2 Global Top 10 and Top 5 Companies by IBS Treatment Revenue in 2019
    • 3.3 IBS Treatment Key Players Head office and Area Served
    • 3.4 Key Players IBS Treatment Product Solution and Service
    • 3.5 Date of Enter into IBS Treatment Market
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type (2015-2026)

    • 4.1 Global IBS Treatment Historic Market Size by Type (2015-2020)
    • 4.2 Global IBS Treatment Forecasted Market Size by Type (2021-2026)

    5 Market Size by Application (2015-2026)

    • 5.1 Global IBS Treatment Market Size by Application (2015-2020)
    • 5.2 Global IBS Treatment Forecasted Market Size by Application (2021-2026)

    6 North America

    • 6.1 North America IBS Treatment Market Size (2015-2020)
    • 6.2 IBS Treatment Key Players in North America (2019-2020)
    • 6.3 North America IBS Treatment Market Size by Type (2015-2020)
    • 6.4 North America IBS Treatment Market Size by Application (2015-2020)

    7 Europe

    • 7.1 Europe IBS Treatment Market Size (2015-2020)
    • 7.2 IBS Treatment Key Players in Europe (2019-2020)
    • 7.3 Europe IBS Treatment Market Size by Type (2015-2020)
    • 7.4 Europe IBS Treatment Market Size by Application (2015-2020)

    8 China

    • 8.1 China IBS Treatment Market Size (2015-2020)
    • 8.2 IBS Treatment Key Players in China (2019-2020)
    • 8.3 China IBS Treatment Market Size by Type (2015-2020)
    • 8.4 China IBS Treatment Market Size by Application (2015-2020)

    9 Japan

    • 9.1 Japan IBS Treatment Market Size (2015-2020)
    • 9.2 IBS Treatment Key Players in Japan (2019-2020)
    • 9.3 Japan IBS Treatment Market Size by Type (2015-2020)
    • 9.4 Japan IBS Treatment Market Size by Application (2015-2020)

    10 Southeast Asia

    • 10.1 Southeast Asia IBS Treatment Market Size (2015-2020)
    • 10.2 IBS Treatment Key Players in Southeast Asia (2019-2020)
    • 10.3 Southeast Asia IBS Treatment Market Size by Type (2015-2020)
    • 10.4 Southeast Asia IBS Treatment Market Size by Application (2015-2020)

    11 India

    • 11.1 India IBS Treatment Market Size (2015-2020)
    • 11.2 IBS Treatment Key Players in India (2019-2020)
    • 11.3 India IBS Treatment Market Size by Type (2015-2020)
    • 11.4 India IBS Treatment Market Size by Application (2015-2020)

    12 Central & South America

    • 12.1 Central & South America IBS Treatment Market Size (2015-2020)
    • 12.2 IBS Treatment Key Players in Central & South America (2019-2020)
    • 12.3 Central & South America IBS Treatment Market Size by Type (2015-2020)
    • 12.4 Central & South America IBS Treatment Market Size by Application (2015-2020)

    13 Key Players Profiles

    • 13.1 Allergan Plc (Ireland)
      • 13.1.1 Allergan Plc (Ireland) Company Details
      • 13.1.2 Allergan Plc (Ireland) Business Overview
      • 13.1.3 Allergan Plc (Ireland) IBS Treatment Introduction
      • 13.1.4 Allergan Plc (Ireland) Revenue in IBS Treatment Business (2015-2020))
      • 13.1.5 Allergan Plc (Ireland) Recent Development
    • 13.2 Sucampo Pharmaceuticals (U.S.)
      • 13.2.1 Sucampo Pharmaceuticals (U.S.) Company Details
      • 13.2.2 Sucampo Pharmaceuticals (U.S.) Business Overview
      • 13.2.3 Sucampo Pharmaceuticals (U.S.) IBS Treatment Introduction
      • 13.2.4 Sucampo Pharmaceuticals (U.S.) Revenue in IBS Treatment Business (2015-2020)
      • 13.2.5 Sucampo Pharmaceuticals (U.S.) Recent Development
    • 13.3 Ironwood Pharmaceuticals, Inc. (U.S.)
      • 13.3.1 Ironwood Pharmaceuticals, Inc. (U.S.) Company Details
      • 13.3.2 Ironwood Pharmaceuticals, Inc. (U.S.) Business Overview
      • 13.3.3 Ironwood Pharmaceuticals, Inc. (U.S.) IBS Treatment Introduction
      • 13.3.4 Ironwood Pharmaceuticals, Inc. (U.S.) Revenue in IBS Treatment Business (2015-2020)
      • 13.3.5 Ironwood Pharmaceuticals, Inc. (U.S.) Recent Development
    • 13.4 Astellas Pharma Inc. (Japan)
      • 13.4.1 Astellas Pharma Inc. (Japan) Company Details
      • 13.4.2 Astellas Pharma Inc. (Japan) Business Overview
      • 13.4.3 Astellas Pharma Inc. (Japan) IBS Treatment Introduction
      • 13.4.4 Astellas Pharma Inc. (Japan) Revenue in IBS Treatment Business (2015-2020)
      • 13.4.5 Astellas Pharma Inc. (Japan) Recent Development
    • 13.5 Bausch Health
      • 13.5.1 Bausch Health Company Details
      • 13.5.2 Bausch Health Business Overview
      • 13.5.3 Bausch Health IBS Treatment Introduction
      • 13.5.4 Bausch Health Revenue in IBS Treatment Business (2015-2020)
      • 13.5.5 Bausch Health Recent Development
    • 13.6 Abbott Laboratories (U.S.)
      • 13.6.1 Abbott Laboratories (U.S.) Company Details
      • 13.6.2 Abbott Laboratories (U.S.) Business Overview
      • 13.6.3 Abbott Laboratories (U.S.) IBS Treatment Introduction
      • 13.6.4 Abbott Laboratories (U.S.) Revenue in IBS Treatment Business (2015-2020)
      • 13.6.5 Abbott Laboratories (U.S.) Recent Development
    • 13.7 Synergy Pharmaceuticals, Inc. (U.S.)
      • 13.7.1 Synergy Pharmaceuticals, Inc. (U.S.) Company Details
      • 13.7.2 Synergy Pharmaceuticals, Inc. (U.S.) Business Overview
      • 13.7.3 Synergy Pharmaceuticals, Inc. (U.S.) IBS Treatment Introduction
      • 13.7.4 Synergy Pharmaceuticals, Inc. (U.S.) Revenue in IBS Treatment Business (2015-2020)
      • 13.7.5 Synergy Pharmaceuticals, Inc. (U.S.) Recent Development
    • 13.8 Ardelyx, Inc. (U.S.)
      • 13.8.1 Ardelyx, Inc. (U.S.) Company Details
      • 13.8.2 Ardelyx, Inc. (U.S.) Business Overview
      • 13.8.3 Ardelyx, Inc. (U.S.) IBS Treatment Introduction
      • 13.8.4 Ardelyx, Inc. (U.S.) Revenue in IBS Treatment Business (2015-2020)
      • 13.8.5 Ardelyx, Inc. (U.S.) Recent Development
    • 13.9 Nestle (Switzerland)
      • 13.9.1 Nestle (Switzerland) Company Details
      • 13.9.2 Nestle (Switzerland) Business Overview
      • 13.9.3 Nestle (Switzerland) IBS Treatment Introduction
      • 13.9.4 Nestle (Switzerland) Revenue in IBS Treatment Business (2015-2020)
      • 13.9.5 Nestle (Switzerland) Recent Development
    • 13.10 Sebela Pharmaceuticals (Ireland)
      • 13.10.1 Sebela Pharmaceuticals (Ireland) Company Details
      • 13.10.2 Sebela Pharmaceuticals (Ireland) Business Overview
      • 13.10.3 Sebela Pharmaceuticals (Ireland) IBS Treatment Introduction
      • 13.10.4 Sebela Pharmaceuticals (Ireland) Revenue in IBS Treatment Business (2015-2020)
      • 13.10.5 Sebela Pharmaceuticals (Ireland) Recent Development
    • 13.11 Probi (Sweden)
      • 10.11.1 Probi (Sweden) Company Details
      • 10.11.2 Probi (Sweden) Business Overview
      • 10.11.3 Probi (Sweden) IBS Treatment Introduction
      • 10.11.4 Probi (Sweden) Revenue in IBS Treatment Business (2015-2020)
      • 10.11.5 Probi (Sweden) Recent Development
    • 13.12 Alfasigma USA, Inc. (Italy)
      • 10.12.1 Alfasigma USA, Inc. (Italy) Company Details
      • 10.12.2 Alfasigma USA, Inc. (Italy) Business Overview
      • 10.12.3 Alfasigma USA, Inc. (Italy) IBS Treatment Introduction
      • 10.12.4 Alfasigma USA, Inc. (Italy) Revenue in IBS Treatment Business (2015-2020)
      • 10.12.5 Alfasigma USA, Inc. (Italy) Recent Development
    • 13.13 RedHill Biopharma Ltd. (Israel)
      • 10.13.1 RedHill Biopharma Ltd. (Israel) Company Details
      • 10.13.2 RedHill Biopharma Ltd. (Israel) Business Overview
      • 10.13.3 RedHill Biopharma Ltd. (Israel) IBS Treatment Introduction
      • 10.13.4 RedHill Biopharma Ltd. (Israel) Revenue in IBS Treatment Business (2015-2020)
      • 10.13.5 RedHill Biopharma Ltd. (Israel) Recent Development
    • 13.14 AstraZeneca (U.K)
      • 10.14.1 AstraZeneca (U.K) Company Details
      • 10.14.2 AstraZeneca (U.K) Business Overview
      • 10.14.3 AstraZeneca (U.K) IBS Treatment Introduction
      • 10.14.4 AstraZeneca (U.K) Revenue in IBS Treatment Business (2015-2020)
      • 10.14.5 AstraZeneca (U.K) Recent Development
    • 13.15 Ipsen (France)
      • 10.15.1 Ipsen (France) Company Details
      • 10.15.2 Ipsen (France) Business Overview
      • 10.15.3 Ipsen (France) IBS Treatment Introduction
      • 10.15.4 Ipsen (France) Revenue in IBS Treatment Business (2015-2020)
      • 10.15.5 Ipsen (France) Recent Development
    • 13.16 Novartis AG (Switzerland)
      • 10.16.1 Novartis AG (Switzerland) Company Details
      • 10.16.2 Novartis AG (Switzerland) Business Overview
      • 10.16.3 Novartis AG (Switzerland) IBS Treatment Introduction
      • 10.16.4 Novartis AG (Switzerland) Revenue in IBS Treatment Business (2015-2020)
      • 10.16.5 Novartis AG (Switzerland) Recent Development
    • 13.17 Takeda Pharmaceutical Company Ltd (Japan)
      • 10.17.1 Takeda Pharmaceutical Company Ltd (Japan) Company Details
      • 10.17.2 Takeda Pharmaceutical Company Ltd (Japan) Business Overview
      • 10.17.3 Takeda Pharmaceutical Company Ltd (Japan) IBS Treatment Introduction
      • 10.17.4 Takeda Pharmaceutical Company Ltd (Japan) Revenue in IBS Treatment Business (2015-2020)
      • 10.17.5 Takeda Pharmaceutical Company Ltd (Japan) Recent Development
    • 13.18 Synthetic Biologics, Inc. (U.S.)
      • 10.18.1 Synthetic Biologics, Inc. (U.S.) Company Details
      • 10.18.2 Synthetic Biologics, Inc. (U.S.) Business Overview
      • 10.18.3 Synthetic Biologics, Inc. (U.S.) IBS Treatment Introduction
      • 10.18.4 Synthetic Biologics, Inc. (U.S.) Revenue in IBS Treatment Business (2015-2020)
      • 10.18.5 Synthetic Biologics, Inc. (U.S.) Recent Development
    • 13.19 Protagonist Therapeutics Inc. (U.S.)
      • 10.19.1 Protagonist Therapeutics Inc. (U.S.) Company Details
      • 10.19.2 Protagonist Therapeutics Inc. (U.S.) Business Overview
      • 10.19.3 Protagonist Therapeutics Inc. (U.S.) IBS Treatment Introduction
      • 10.19.4 Protagonist Therapeutics Inc. (U.S.) Revenue in IBS Treatment Business (2015-2020)
      • 10.19.5 Protagonist Therapeutics Inc. (U.S.) Recent Development
    • 13.20 Pfizer Inc (U.S.)
      • 10.20.1 Pfizer Inc (U.S.) Company Details
      • 10.20.2 Pfizer Inc (U.S.) Business Overview
      • 10.20.3 Pfizer Inc (U.S.) IBS Treatment Introduction
      • 10.20.4 Pfizer Inc (U.S.) Revenue in IBS Treatment Business (2015-2020)
      • 10.20.5 Pfizer Inc (U.S.) Recent Development
    • 13.21 Lexicon Pharmaceuticals, Inc. (U.S.)
      • 10.21.1 Lexicon Pharmaceuticals, Inc. (U.S.) Company Details
      • 10.21.2 Lexicon Pharmaceuticals, Inc. (U.S.) Business Overview
      • 10.21.3 Lexicon Pharmaceuticals, Inc. (U.S.) IBS Treatment Introduction
      • 10.21.4 Lexicon Pharmaceuticals, Inc. (U.S.) Revenue in IBS Treatment Business (2015-2020)
      • 10.21.5 Lexicon Pharmaceuticals, Inc. (U.S.) Recent Development
    • 13.22 Innovate Biopharmaceuticals (U.S.)
      • 10.22.1 Innovate Biopharmaceuticals (U.S.) Company Details
      • 10.22.2 Innovate Biopharmaceuticals (U.S.) Business Overview
      • 10.22.3 Innovate Biopharmaceuticals (U.S.) IBS Treatment Introduction
      • 10.22.4 Innovate Biopharmaceuticals (U.S.) Revenue in IBS Treatment Business (2015-2020)
      • 10.22.5 Innovate Biopharmaceuticals (U.S.) Recent Development

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
        • 15.1.2 Data Source
      • 15.2 Disclaimer

      IBS Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global IBS Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

      The key players covered in this study
      Allergan Plc (Ireland)
      Sucampo Pharmaceuticals (U.S.)
      Ironwood Pharmaceuticals, Inc. (U.S.)
      Astellas Pharma Inc. (Japan)
      Bausch Health
      Abbott Laboratories (U.S.)
      Synergy Pharmaceuticals, Inc. (U.S.)
      Ardelyx, Inc. (U.S.)
      Nestle (Switzerland)
      Sebela Pharmaceuticals (Ireland)
      Probi (Sweden)
      Alfasigma USA, Inc. (Italy)
      RedHill Biopharma Ltd. (Israel)
      AstraZeneca (U.K)
      Ipsen (France)
      Novartis AG (Switzerland)
      Takeda Pharmaceutical Company Ltd (Japan)
      Synthetic Biologics, Inc. (U.S.)
      Protagonist Therapeutics Inc. (U.S.)
      Pfizer Inc (U.S.)
      Lexicon Pharmaceuticals, Inc. (U.S.)
      Innovate Biopharmaceuticals (U.S.)

      Market segment by Type, the product can be split into
      IBS-D
      IBS-C
      IBS-M
      Market segment by Application, split into
      Hospitals
      Clinics
      Research Laboratories

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America



      Summary:
      IBS Treatment Market Research Report is about IBS Treatment Industry study. Get complete IBS Treatment market research report published after Market Study, Industrial Analysis with Trends & Statistics. IBS Treatment Market Report is a syndicated report for Investors and Manufacturer to understand Market Demand, Growth, trends and Factor Influencing market in upcoming years.



      REPORT YOU MIGHT BE INTERESTED